EC Number |
Protein Variants |
Reference |
---|
3.4.21.118 | C108S |
oligonucleotide-directed mutagenesis, reduced Km, increased kcat, increased activity with substrate tert-butyloxycarbonyl-Val-Pro-Arg-4-methylcoumaryl-7-amide |
647328 |
3.4.21.118 | C145S |
oligonucleotide-directed mutagenesis of disulfide bond SS3, reduced Km and kcat, increased activity with substrate tert-butyloxycarbonyl-Val-Pro-Arg-4-methylcoumaryl-7-amide |
647328 |
3.4.21.118 | C208S |
oligonucleotide-directed mutagenesis of disulfide bond SS6, highly reduced Km and reduced kcat, increased activity with substrate tert-butyloxycarbonyl-Val-Pro-Arg-4-methylcoumaryl-7-amide |
647328 |
3.4.21.118 | C233S |
oligonucleotide-directed mutagenesis, highly reduced Km and slightly reduced kcat, reduced activity with substrate tert-butyloxycarbonyl-Val-Pro-Arg-4-methylcoumaryl-7-amide |
647328 |
3.4.21.118 | C246S |
oligonucleotide-directed mutagenesis, reduced Km and kcat, decreased activity with substrate tert-butyloxycarbonyl-Val-Pro-Arg-4-methylcoumaryl-7-amide |
647328 |
3.4.21.118 | C39S |
oligonucleotide-directed mutagenesis of disulfide bond SS1, increased Km, reduced kcat, reduced activity with substrate tert-butyloxycarbonyl-Val-Pro-Arg-4-methylcoumaryl-7-amide |
647328 |
3.4.21.118 | C7S |
oligonucleotide-directed mutagenesis, reduced Km and kcat, slightly decreased activity with substrate tert-butyloxycarbonyl-Val-Pro-Arg-4-methylcoumaryl-7-amide |
647328 |
3.4.21.118 | D206V |
oligonucleotide-directed mutagenesis, reduced Km and highly reduced kcat, decreased activity with substrate tert-butyloxycarbonyl-Val-Pro-Arg-7-amino-4-methylcoumarin |
647328 |
3.4.21.118 | medicine |
enzyme expression in epithelial ovarian tumors correlates significantly with favorable patient survival. Use of enzyme as a prognostic marker in patients with ovarian cancer |
670447 |
3.4.21.118 | more |
a human-specific T to A mutation triggers the change of splicing pattern. Mutation is not only necessary but also sufficient for type II expression |
680086 |